We are live on ! Find out more
OPU

Omni Partners US Portfolio holdings

AUM $1.95B
This Fund
S&P 500
This Quarter Est. Return
+13.28%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.27B
AUM Growth
–
Cap. Flow
+$2.08B
Cap. Flow %
91.71%
Top 10 Hldgs %
60.91%
Holding
226
New
226
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$220M
2
MXIM
Maxim Integrated Products
MXIM
+$217M
3
XLNX
Xilinx Inc
XLNX
+$177M
4
NUAN
Nuance Communications, Inc.
NUAN
+$119M
5
WORK
Slack Technologies, Inc.
WORK
+$108M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 20.95%
2 Healthcare 18.72%
3 Financials 17.48%
4 Consumer Discretionary 8.17%
5 Communication Services 4.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALXN
1
DELISTED
Alexion Pharmaceuticals
ALXN
$326M 14.36%
+1,283,115
New +$220M
MXIM
2
DELISTED
Maxim Integrated Products
MXIM
$234M 10.31%
+2,220,445
New +$217M
XLNX
3
DELISTED
Xilinx Inc
XLNX
$201M 8.87%
+1,392,018
New +$177M
NUAN
4
DELISTED
Nuance Communications, Inc.
NUAN
$123M 5.42%
+2,260,854
New +$119M
WORK
5
DELISTED
Slack Technologies, Inc.
WORK
$111M 4.91%
+2,514,346
New +$108M
INFO
6
DELISTED
IHS Markit Ltd. Common Shares
INFO
$95.5M 4.21%
+848,117
New +$90M
PRAH
7
DELISTED
PRA Health Sciences, Inc.
PRAH
$90M 3.97%
+544,675
New +$90.9M
NAV
8
DELISTED
Navistar International
NAV
$73.8M 3.25%
+1,658,578
New +$73.4M
WTW icon
9
Willis Towers Watson
WTW
$27.1B
$64.3M 2.84%
+279,651
New +$69.5M
TLND
10
DELISTED
Talend S.A. American Depositary Shares
TLND
$62.9M 2.77%
+959,150
New +$62.1M
CNST
11
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$61.4M 2.7%
+1,815,117
New +$46.3M
PFPT
12
DELISTED
Proofpoint, Inc.
PFPT
$60.4M 2.66%
+347,840
New +$56.4M
CHNG
13
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$54.3M 2.39%
+2,357,993
New +$54.2M
GRA
14
DELISTED
W.R. Grace & Co.
GRA
$47.2M 2.08%
+682,274
New +$45.9M
BPFH
15
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
$44.1M 1.95%
+2,992,815
New +$43.8M
HOME
16
DELISTED
At Home Group Inc.
HOME
$26.4M 1.16%
+716,494
New +$24.4M
WTRE
17
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
$25M 1.1%
+713,569
New +$24.9M
CLDR
18
DELISTED
Cloudera, Inc.
CLDR
$24.3M 1.07%
+1,532,988
New +$20.9M
ACAH
19
DELISTED
Atlantic Coastal Acquisition Corp. Class A Common Stock
ACAH
$16.8M 0.74%
+1,738,040
New +$16.8M
SOGO
20
DELISTED
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
$16.6M 0.73%
+1,941,866
New +$16.3M
KSU
21
DELISTED
Kansas City Southern
KSU
$13.5M 0.6%
+47,766
New +$13.8M
BPY
22
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
$11.6M 0.51%
+612,199
New +$11.2M
MKTW icon
23
MarketWise
MKTW
$53.9M
$11.2M 0.49%
+56,346
New +$11.2M
LDL
24
DELISTED
Lydall, Inc.
LDL
$10.2M 0.45%
+168,289
New +$6.47M
GLS
25
DELISTED
Gelesis Holdings, Inc.
GLS
$8.94M 0.39%
+913,366
New +$8.98M
1
2 3 4 5

Similar funds

XEA
XN Exponent Advisors New York $2.09B AUM 32.83% 1-Year Est. Return
AIC
Ameritas Investment Company Lincoln, Nebraska $2.17B AUM 26.5% 1-Year Est. Return
QAM
QCI Asset Management Pittsford, New York $1.72B AUM 25.41% 1-Year Est. Return
BU
BBVA USA Birmingham, Alabama $1.71B AUM
H
Hexavest Montreal, Quebec, Canada $1.64B AUM 28.34% 1-Year Est. Return
FMW
Farr Miller & Washington Washington, District of Columbia $1.53B AUM 32.74% 1-Year Est. Return
MAFM
Mid Atlantic Financial Management Pittsburgh, Pennsylvania $1.49B AUM 24.08% 1-Year Est. Return
BOS
Bingham Osborn & Scarborough San Francisco, California $1.42B AUM 27.88% 1-Year Est. Return

Omni Partners US's Q2 2021 Portfolio in Review

Q2 2021 is the first quarter with a 13F filing on record for Omni Partners US, which disclosed 226 positions worth $2.27B. Its ten largest holdings account for 61% of the portfolio.

Its largest position is Alexion Pharmaceuticals: 1,283,115 shares worth $326M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, followed by Healthcare and Financials.

  • Omni Partners US's largest Q2 2021 buy was Alexion Pharmaceuticals: 1,283,115 shares worth $326M.
  • Omni Partners US's ten largest holdings make up 61% of its $2.27B portfolio in Q2 2021.
  • Omni Partners US disclosed 226 positions in Q2 2021, its first 13F filing on record.

Based on Omni Partners US's 13F filing for Q2 2021, filed 16 Aug 2021.